How have BBH shares performed in 2024?

VanEck Biotech ETF's stock was trading at $165.31 at the beginning of the year. Since then, BBH stock has decreased by 8.1% and is now trading at $151.99. View the best growth stocks for 2024 here .

Are investors shorting VanEck Biotech ETF?

VanEck Biotech ETF saw a increase in short interest in March. As of March 31st, there was short interest totaling 7,800 shares, an increase of 212.0% from the March 15th total of 2,500 shares. Based on an average daily trading volume, of 8,500 shares, the short-interest ratio is presently 0.9 days. View VanEck Biotech ETF's Short Interest .

How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF?

VanEck Biotech ETF announced an annual dividend on Friday, December 15th. Shareholders of record on Tuesday, December 19th will be given a dividend of $0.7127 per share on Friday, December 22nd. The ex-dividend date of this dividend is Monday, December 18th. Read our dividend analysis for BBH .

What does BBH invest in?

VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $412.58 million assets under management.

What stocks does VanEck Biotech ETF hold?

BBH invests in 26 holdings. Some of the stocks in their portfolio include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Regeneron Pharmaceuticals (REGN) , argenx (ARGX) , IQVIA (IQV) , Seagen (SGEN) , ICON Public (ICLR) , Biogen (BIIB) and Moderna (MRNA) .

What is the management fee for VanEck Biotech ETF?

VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%.

What other stocks do shareholders of VanEck Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD) , Inovio Pharmaceuticals (INO) , Pfizer (PFE) , Intel (INTC) , Micron Technology (MU) , Cidara Therapeutics (CDTX) , Quest Diagnostics (DGX) , Novavax (NVAX) .

Who are VanEck Biotech ETF's major shareholders?

VanEck Biotech ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include Aspiriant LLC (0.16%).

How do I buy shares of VanEck Biotech ETF?

Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BBH

VanEck Biotech ETF (BBH) Price, Holdings, & News

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free BBH Stock Alerts

$151.99

-1.01 (-0.66%)

(As of 04/18/2024 ET)

Compare

Today's Range: $151.80
▼
$153.28
50-Day Range: $151.99
▼
$167.01
52-Week Range: $142.51
▼
$171.04

Volume: 3,572 shs
Average Volume: 8,716 shs
Market Capitalization: $410.37 million

Assets Under Management: $412.58 million
Dividend Yield: 0.47%
Net Expense Ratio: 0.35%

Get VanEck Biotech ETF alerts:

About VanEck Biotech ETF (NASDAQ:BBH)

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

BBH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BBH ETF News Headlines

March 29, 2024 | benzinga.com

Future-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYC

March 22, 2024 | seekingalpha.com

GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment

April 19, 2024 | InvestorPlace (Ad)

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

January 30, 2024 | msn.com

VanEck CEO Says Cryptos Deserve A Place In Everyone's Portfolio

December 19, 2023 | msn.com

VanEck Vectors Biotech ETF declares annual distribution of $0.7127

December 9, 2023 | seekingalpha.com

BBH: A Solid Way To Play A Comeback In Biotech

October 24, 2023 | investing.com

BBH ETF Stock Price History

September 13, 2023 | msn.com

BBH: Our Favorite Biotech ETF Can Keep Outperforming

April 19, 2024 | InvestorPlace (Ad)

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

August 7, 2023 | morningstar.com

VanEck ETFs

See More Headlines

Receive BBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Van Eck
Fund Name: VanEck Biotech ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:BBH
Inception Date: 12/20/2011
Fund Manager: Hao-Hung Peter Liao, Guo Hua Jason Jin
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: Market Vectors US Listed Biotech 25 Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: Global
Number of Holdings: 26

Fund Statistics

Assets Under Management: $412.58 million
Average Daily Volume: $8,597.70
Discount/Premium: 0.00%

Administrator, Advisor and Custodian

Administrator: Van Eck Associates Corporation
Advisor: Van Eck Associates Corporation
Custodian: State Street Bank and Trust Company
Distributor: Van Eck Securities Corporation
Transfer Agent: State Street Bank and Trust Company
Trustee: N/A
Lead Market Maker: Virtu Financial

Options

Optionable: N/A
Short Interest: 7,800 shs

Miscellaneous

Outstanding Shares: 2,700,000
Beta: 0.74
Creation Unit: 50,000
Creation Fee: $500.00

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

VanEck Biotech ETF Expenses

Type	BBH	Health Care ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.35%	0.56%	0.54%	0.48%	0.51%
Other Expenses	0.00%	0.40%	0.54%	0.34%	0.58%
Total Expense	0.35%	0.72%	0.70%	0.58%	0.70%
Fee Waiver	0.00%	-0.53%	-0.55%	-0.22%	-0.57%
Net Expense	0.35%	0.60%	0.60%	0.54%	0.58%

VanEck Biotech ETF (BBH) Holdings & Exposure

Top 10 BBH Holdings

BBH Sector Exposure

BBH Industry Exposure

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

BBH ETF - Frequently Asked Questions

How have BBH shares performed in 2024?: VanEck Biotech ETF's stock was trading at $165.31 at the beginning of the year. Since then, BBH stock has decreased by 8.1% and is now trading at $151.99.
View the best growth stocks for 2024 here.
Are investors shorting VanEck Biotech ETF?: VanEck Biotech ETF saw a increase in short interest in March. As of March 31st, there was short interest totaling 7,800 shares, an increase of 212.0% from the March 15th total of 2,500 shares. Based on an average daily trading volume, of 8,500 shares, the short-interest ratio is presently 0.9 days.
View VanEck Biotech ETF's Short Interest.
How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF?: VanEck Biotech ETF announced an annual dividend on Friday, December 15th. Shareholders of record on Tuesday, December 19th will be given a dividend of $0.7127 per share on Friday, December 22nd. The ex-dividend date of this dividend is Monday, December 18th.
Read our dividend analysis for BBH.
What does BBH invest in?: VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $412.58 million assets under management.
What stocks does VanEck Biotech ETF hold?: BBH invests in 26 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), argenx (ARGX), IQVIA (IQV), Seagen (SGEN), ICON Public (ICLR), Biogen (BIIB) and Moderna (MRNA).

What is the management fee for VanEck Biotech ETF?: VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%.
What other stocks do shareholders of VanEck Biotech ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX).
Who are VanEck Biotech ETF's major shareholders?: VanEck Biotech ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include Aspiriant LLC (0.16%).
How do I buy shares of VanEck Biotech ETF?: Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BBH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

VanEck Biotech ETF (BBH) Price, Holdings, & News

About VanEck Biotech ETF (NASDAQ:BBH)

BBH Stock Price History

BBH ETF News Headlines

Fund Details

Fund Focus

Fund Statistics

Administrator, Advisor and Custodian

Options

Miscellaneous

VanEck Biotech ETF Expenses

VanEck Biotech ETF (BBH) Holdings & Exposure

Top 10 BBH Holdings

BBH Sector Exposure

BBH Industry Exposure

Similar ETFs

Institutional Ownership

BBH ETF - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info